Four blue states are asking the U.S. Food and Drug Administration to remove restrictions on a key abortion medication and make it easier for clinicians to prescribe and dispense it - an attempt to widen access as the agency plans to review the pill’s safety.

The states consider it a move to force the F.D.A. to review and acknowledge extensive research showing the pill’s safety.